Process Revision for Drug Response Applications
The U.S. Food and Drug Administration (FDA) is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.
The U.S. Food and Drug Administration (FDA) is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.
(FDA: Washington, D.C.) -- The U.S.
(NCQA: Washington, D.C.) -- The National Committee for Quality Assurance recently released its 2007 annual report, “Coming Home to Better Care.” The report looks at the promise of the patient-centered medical home, a promising approach that seeks to strengthen the patient-physician relationship
(Quality Digest: Chico, California) -- Be sure to check out the new, fully redesigned Quality Digest homepage and web site.
(IBM: Armonk, New York) -- IBM’s vision statement, "Healthcare 2015 and Care Delivery: Delivery models refined, competencies" defined calls for
(American Society for Quality: Milwaukee, Wisconsin) -- Physician profiles are becoming an integral part of hospital appointment, reappointment, and
(American Society for Quality: Milwaukee, Wisconsin) -- The American Society for Quality has submitted guidelines to the Office of Human Research Pro
(Octagon Research Solutions Inc.: Wayne, Pennsylvania) -- Octagon Research Solutions Inc., a provider of software and services to the life sciences industry, has announced a new service offering, CheckPoint.
“Today's progress report reflects strong and sustained cooperation by both nations to strengthen the safety of food products exp
(HHS: Washington, D.C.) -- Efforts are underway at the U.S.
© 2026 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.